Developmental dysplasia of the hip: definition, recognition, and prevention of late sequelae

Robert B Cady1

  • 1Crouse Hospital Pediatric Orthopedics, Syracuse, NY, USA. robertcady@aol.com

Pediatric Annals
|February 24, 2006
PubMed

Insights

Preventing late diagnosis of developmental dysplasia of the hip (DDH) requires skilled infant hip exams. Early detection minimizes long-term hip problems and arthritis, but some cases remain undetected at birth.

Area of Science:

  • Pediatric Orthopedics
  • Developmental Dysplasia of the Hip (DDH)
  • Neonatal Screening

Background:

  • Late presentation of developmental dysplasia of the hip (DDH) causes significant distress and potential litigation.
  • Current diagnostic methods can minimize, but not entirely eliminate, late DDH diagnosis.
  • Undetected DDH at birth may lead to premature degenerative arthritis, increasing morbidity and healthcare costs.

Purpose of the Study:

  • To emphasize the critical importance of early detection and prevention of late-presenting developmental dysplasia of the hip (DDH).
  • To highlight the need for improved clinical skills in neonatal hip examination.
  • To discuss strategies for enhancing the detection and management of DDH in infants.

Main Methods:

  • Review of current diagnostic techniques for developmental dysplasia of the hip (DDH).
  • Emphasis on the necessity of repeated, careful physical examinations of infants within the first year of life.
  • Discussion of educational strategies for clinicians, including specialized training and formal screening programs.

Main Results:

  • Approximately 15% of developmental dysplasia of the hip (DDH) cases are not detectable at birth, even with expert examination or ultrasonography.
  • Thorough documentation of infant hip examinations is crucial for clinical practice and medicolegal protection.
  • A combination of careful physical examination and imaging (ultrasonography or X-rays) for at-risk infants is the optimal strategy.

Conclusions:

  • Improving clinicians' proficiency in neonatal hip examination is paramount to prevent late presentations of DDH.
  • Early identification and treatment of DDH in newborns can reduce the incidence of adult degenerative hip arthritis.
  • Systematic screening programs and enhanced documentation practices are essential for minimizing the impact of DDH.

Related Concept Videos

Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...